Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2019 01:00 ET | Source: ORPHAZYME A/S

Orphazyme’s arimoclomol receives US Fast Track designation in sporadic Inclusion Body Myositis

Orphazyme A/SCompany announcement No....
April 23, 2019 06:39 ET | Source: ORPHAZYME A/S

Orphazyme’s Phase II/III trial in sporadic Inclusion Body Myositis fully enrolled

Orphazyme A/SCompany announcement No. 13/2019 ...
December 15, 2017 09:20 ET | Source: ORPHAZYME A/S

Orphazyme assumes sponsorship of Phase II/III sIBM trial

Investor newsNo. 01/2017 Orphazyme assumes sponsorship of Phase II/III sIBM trial On December 14, 2017, Orphazyme A/S, University of Kansas Medical Center, and UCL announced that Orphazyme...